British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
复制标题
DOI：
10.1177/0269881119855343
复制
发表时间：
2019-07-04
影响因子：
4.1
通讯作者：
Sharpley, Ann
中科院分区：
文献类型：
--
作者：
Wilson, Sue;Anderson, Kirstie;Sharpley, Ann
这份英国精神药理学协会指南取代了2010年发布的原始版本，并包含了更新的信息和建议。2017年10月在伦敦举行了一次共识会议，该领域公认的专家和倡导者出席了会议。他们被要求提供文献回顾和确定他们所在领域的证据标准，重点是荟萃分析、系统评价和随机对照试验，以及当前临床实践的最新情况。每次陈述之后都会进行讨论，目的是在证据和/或临床经验被认为足够的情况下达成共识，或者以其他方式将该领域标记为未来研究的方向。会议记录草稿已分发给所有发言者征求意见，并被纳入最后发言。
This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in London in October 2017 attended by recognised experts and advocates in the field. They were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aiming to reach consensus where the evidence and/or clinical experience was considered adequate, or otherwise to flag the area as a direction for future research. A draft of the proceedings was circulated to all speakers for comments, which were incorporated into the final statement.